Skip to main content
. 2021 Oct 28;191(5):2193–2200. doi: 10.1007/s11845-021-02778-x

Table 2.

Participants’ opinions and awareness on HZ and PN vaccines and the vaccination rates at 1-year follow-up

n (%)
HZ PN
Knows about the disease Yes 102 (65.8) 150 (96.8)
No 53 (34.2) 5 (3.2)
Perception of the disease severity Very mild 1 (1.0) 1 (0.7)
Mild 19 (18.6) 4 (2.7)
Moderate 2 (2.0) 2 (1.3)
Severe 61 (39.4) 102 (68.0)
Very severe 19 (18.6) 41 (27.3)
Already had information on the disease By physician 8 (7.8) 19 (12.7)
By pharmacist 3 (2.9) 1 (0.7)
By family and friends 65 (63.7) 93 (60.0)
By media 8 (7.8) 11 (7.3)
By having disease previously 16 (15.7) 20 (13.3)
By him/herself 2 (2.0) 6 (4.0)
Knows about the vaccine Yes 13 (12.7) 60 (40.0)
No 89 (87.3) 90 (60.0)
Had thought about having vaccine before Yes 1 (7.7) 11 (18.3)
No 12 (92.3) 49 (81.7)
Preference of having vaccine following pharmacist counselling in general Yes 80 (51.6) 82 (52.9)
No 55 (35.5) 52 (33.5)
Not sure 20 (12.9) 21 (13.5)
Preference of having vaccine following pharmacist counselling about reimbursement status Yes 41 (26.5) 90 (58.1)
No 83 (53.5) 43 (27.7)
Not sure 31 (20.0) 22 (14.2)
Vaccination status 1 year after pharmacist’s interview Yes 1 (0.8) 7 (5.7)
No 121 (99.2) 115 (94.3)

HZ herpes zoster, PN pneumococcal